First Time Loading...
G

Gemini Therapeutics Inc
NASDAQ:GMTX

Watchlist Manager
Gemini Therapeutics Inc
NASDAQ:GMTX
Watchlist
Price: 19.89 USD 47.33% Market Closed
Updated: May 12, 2024

Cash Flow Statement

Cash Flow Statement
Gemini Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2020 Dec-2021 Dec-2022
Operating Cash Flow
Net Income
(1)
(72)
(47)
Depreciation & Amortization
0
0
0
Other Non-Cash Items
(0)
10
2
Cash Interest Paid
0
0
0
Change in Working Capital
0
2
2
Cash from Operating Activities
(0)
N/A
(60)
-14 237%
(42)
+29%
Investing Cash Flow
Capital Expenditures
0
(0)
(0)
Other Items
(121)
0
0
Cash from Investing Activities
(121)
N/A
0
N/A
(0)
N/A
Financing Cash Flow
Net Issuance of Common Stock
125
0
54
Net Issuance of Debt
0
(5)
0
Other
(3)
196
95
Cash from Financing Activities
122
N/A
191
+56%
149
-22%
Change in Cash
Net Change in Cash
1
N/A
132
+10 801%
107
-19%
Free Cash Flow
Free Cash Flow
(0)
N/A
(60)
-14 254%
(42)
+29%

See Also

Discover More